LinkedIn·Tuesday, 18 August 2026·7d ago
Are you ready to make the business case for RBQM? Join us for our upcoming webinar, where experts from CluePoints and the Tufts Center for…
CluePoints
15,583 followers
Are you ready to make the business case for RBQM?
Join us for our upcoming webinar, where experts from CluePoints and the Tufts Center for the Study of Drug Development will explore new peer-reviewed research quantifying the financial value of Risk-Based Quality Management (RBQM).
We’ll explore what the evidence means for sponsors and CROs - from ROI and development timelines to making the case for investment and wider portfolio adoption.
But we want to answer the questions that matter most to you.
What would you like to ask our RBQM experts?
When you register, submit your question for the opportunity to have it answered live during the webinar.
Already registered? Drop your question in the comments below and we’ll make sure it gets to our experts.
Register now: https://hubs.ly/Q04sYSbp0
#RBQM #ClinicalTrials #ClinicalResearch #RiskBasedQualityManagement #Pharma #CRO #ClinicalOperations
♥ 19↻ 1
View on LinkedIn Cross-referenced
Related on the wire
The RBQMLive 2026 agenda is live. Six years in, and the conversation has moved from "should we do RBQM" to "how do we prove it works." That…
83% of sites improved trial quality when central statistical monitoring was applied. Only 56% improved without it. In the Summer issue of…
We’re bringing the launch to the rooftop. 🎉 Join CluePoints at Urban Oak Rooftop Bar on Tuesday, September 15, as we celebrate the launch…
We know RBQM improves oversight. But what's it actually worth? In a new Q&A with ACRP, Sylviane de Viron (CluePoints) and Abigail Dirks, MS…
The CRA role isn't shrinking. It's being elevated. For years, the job meant high-volume source data verification and box-checking against…
Real-world data is only as valuable as it is trustworthy. In her latest piece for PharmaLive, CluePoints Senior Strategic Consultant Sophie…